Table of Contents Author Guidelines Submit a Manuscript

History and Current Status of Evidence-Based Korean Medicine

Call for Papers

The biomedical effects of natural products have been increasingly identified. Korean medicine originates from prehistoric times and shares its origin with Chinese medicine. However, Korean medicine, compared with the Chinese medicine, is not well known relatively. Though Korean medicine and Chinese medicine have a lot in common, Korean medicine has developed its own realm by developing unique approaches and research— "Four-Constitution (Sasang Constitutional) Medicine" as one of the diagnostic tools and Saam acupuncture as one of the treatments. In recent years, Korean medicine expanded its usages, thus, by integrating both traditional and modern approaches. Korean medicine covers many complementary and alternative approaches that are actively validated and developed. These efforts in the field of Korean medicine have been, and will be, an important contribution to the evidence-based complementary and alternative medicine.

In the light of these aims, we invite investigators to contribute original basic research articles, as well as comprehensive review articles, that reflect recent developments of Korean medicine as an evidence-based complementary and alternative approach. The contributing authors are encouraged to focus on Korean medicine as a system distinct from other approaches. A summarizing diagram is recommended to deliver the main results of their works. Potential topics include, but are not limited to:

  • New drugs discovery and development from natural products
  • Current clinical application
  • Latest technologies for clinical evaluation and measurement
  • Implication of Korean medicine in the treatment of refractory diseases, such as cancer, inflammatory diseases, diabetes, and neuronal disorders
  • Biological activities of extracts and isolated compounds from medicinal herbs developed

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 5 April 2013
First Round of ReviewsFriday, 28 June 2013
Publication DateFriday, 23 August 2013

Lead Guest Editor

  • Seong-Gyu Ko, Laboratory of Clinical Biology and Pharmacogenomics and Center for Clinical Research and Genomics, Kyung Hee University, Seoul 130-701, Republic of Korea

Guest Editors

  • Bharat B. Aggarwal, Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, 1901 East Road, Houston, TX 77054, USA
  • Mingyao Liu, School of Life Science and Institute of Biomedical Science, East China Normal University, Shanghai 200241, China
  • Chang Shik Yin, Acupuncture and Meridian Science Research Center, Kyung Hee University, Seoul 130-701, Republic of Korea
  • Dong Hoon Jin, Institute for Innovative Cancer Research, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea
  • Bo-Hyoung Jang, Office of Health Services Research, National Evidence-Based Healthcare Collaborating Agency, Seoul 110-450, Republic of Korea